Graceway Pharma Buys Derma Molecule Rights from Pfizer

Graceway Pharmaceuticals LLC, a portfolio company of GTCR Golder Rauner, has agreed to acquire the global commercial rights to three investigational dermatological molecules from Pfizer (NYSE: PFE). No financial terms were disclosed.

DealsNorth AmericaUSBriefs